<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2022-4-85-91</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-752</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Клинико-корреляционный анализ исходов больных из группы риска по шизофрении</article-title><trans-title-group xml:lang="en"><trans-title>Clinical-correlative analysis of patients at risk of schizophrenia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8343-168X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омельченко</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Omelchenko</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Анатольевна Омельченко, д. м. н., заведующая отделом, ведущий научный сотрудник</p><p>отдел по подготовке специалистов в области психиатрии</p><p>отдел юношеской психиатрии</p><p>Москва</p></bio><bio xml:lang="en"><p>Maria A. Omelchenko</p><p>Moscow</p></bio><email xlink:type="simple">omelchenko-ma@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4009-4323</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мигалина</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Migalina</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валентина Владимировна Мигалина, к. м. н., научный сотрудник</p><p>отдел юношеской психиатрии</p><p>Москва</p></bio><bio xml:lang="en"><p>Valentina V. Migalina</p><p>Moscow</p></bio><email xlink:type="simple">migalina-vv@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр психического здоровья</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>18</day><month>12</month><year>2022</year></pub-date><volume>56</volume><issue>4</issue><fpage>85</fpage><lpage>91</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Омельченко М.А., Мигалина В.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Омельченко М.А., Мигалина В.В.</copyright-holder><copyright-holder xml:lang="en">Omelchenko M.A., Migalina V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/752">https://www.bekhterevreview.com/jour/article/view/752</self-uri><abstract><sec><title>   Цель</title><p>   Цель: установление связи между структурой и степенью выраженности психопатологических симптомов и уровнем функционирования у больных из группы риска по шизофрении.</p></sec><sec><title>   Материал и методы</title><p>   Материал и методы: обследованы 38 больных с депрессивным эпизодом с аттенуированными позитивными симптомами (АПС) из группы риска по шизофрении, госпитализированных в 2011-2015 гг. Длительность катамнеза составила 7,3 ± 1,7 лет. На момент обследования все больные находились в состоянии ремиссии. Применялись шкалы HDRS (Hamilton Depression Rating Scale), SOPS (Scale of Prodromal Symptoms) и SANS (Scale for Assessment of Negative Symptoms). Статистический анализ проводился с помощью программы Statistica 12.   Результаты: на момент обследования в 21,1 % случаев установлены диагнозы шизофренического (F25 и F20 по МКБ-10), в 28,9 % — аффективного (F34.0, F31.3, F31.7 и F33.4) спектра, в 13,2 % — в рамках личностной патологии (F60.1, F60.3, F60.8), а в 36,8 % — шизотипического расстройства (F21.3, F21.4, F21.5, F21.8). Социальное функционирование по шкале PSP в 13,2 % оценивалось как высокое (100-81 балл), в 28,9 % и 31,6 % как среднее (80-61 и 60-41 балл соответственно) и в 26,3 % как низкое (менее 40 баллов). Наиболее сильные корреляционные связи (р ˂ 0,05) выявлены между общим баллом по шкале SOPS, баллами по негативной подшкале SOPS, суммарным баллом SANS и PSP (- 0,854, - 0,876, - 0,812 соответственно), подшкалой негативных симптомов SOPS и социально полезной деятельностью PSP (0,831), подшкалой апатия - ангедония SANS и социальными отношениями PSP (0,801).</p></sec><sec><title>   Обсуждение</title><p>   Обсуждение: высокий уровень социального функционирования возможен при условии полной редукции продромальных и депрессивных симптомов, при средних уровнях функционирования определяется в первую очередь нарастающими негативными явлениями, особенно доменом абулии-апатии, а низкий уровень формируется при персистенции АПС, нарастании симптомов дезорганизации и негативной симптоматики.</p></sec><sec><title>   Заключение</title><p>   Заключение: проведенное исследование показало, что исходы первого депрессивного эпизода с симптомами риска по шизофрении в целом характеризуются той или иной степенью снижения социального функционирования, которое нельзя рассматривать как самостоятельное явление, а напротив, как производное выраженности психопатологической симптоматики.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Objective</title><p>   Objective: Establishing a link between the structure and severity of psychopathological symptoms and the level of functioning in patients at risk of schizophrenia.</p></sec><sec><title>   Material and Methods</title><p>   Material and Methods: The study examined 38 patients with a depressive episode with attenuated positive symptoms (APS) from the risk group of schizophrenia hospitalized in 2011-2015. The follow-up was 7.3 ± 1.7 years. At the time of the examination, all patients were in remission. HDRS (Hamilton Depression Rating Scale), SOPS (Scale of Prodromal Symptoms) and (SANS) Scale for Assessment of Negative Symptoms were used. Statistical analysis was carried out using the Statistica 12 program.   Results: At the time of the survey, 21.1% of the cases were diagnosed as schizophrenic (F25 and F20 according to ICD-10), 28.9 % as affective (F34.0, F31.3, F31.7 and F33.4), 13.2 % as personal disorders (F60.1, F60.a, F3.8 per cent) and 36,8 % as schizotypal disorders (F21.3, F21.4, F21.5, F21.8). Social performance on the PSP scale of 13.2 % was rated as high (100-81 points), 28.9 % and 31.6 % as average (80-61 and 60-41 points respectively) and 26.3 % as low (less than 40 points). The strongest correlations (p˂0.05) are found between total scores on the SOPS scale, negative SOPS scores, total SANS score and PSP score (- 0.854, - 0.876, - 0.812 respectively), subscale of negative SOPS symptoms and socially beneficial PSP activity (-0.831) subscale of apathy-anhedonia SANS and social relations PSP (0,801).</p></sec><sec><title>   Discussion</title><p>   Discussion: A high level of social functioning is possible provided there is a complete reduction of the prodromal and depressive symptoms, at medium levels, functioning is determined primarily by increasing negative symptoms, especially the domain of avolition - apathy, and low levels are formed by persistent APS, increasing symptoms of disorganization and negative symptoms.</p></sec><sec><title>   Conclusion</title><p>   Conclusion: The study showed that the outcome of the first depressive episode with the risk symptoms of schizophrenia is generally characterized by some degree of decline in social functioning, which cannot be considered as a phenomenon in its own right, on the contrary, it’s a derivative of psychopathological symptoms.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>группа риска по шизофрении</kwd><kwd>катамнез юношеских депрессий</kwd><kwd>аттенуированные позитивные симптомы</kwd><kwd>функциональный исход</kwd></kwd-group><kwd-group xml:lang="en"><kwd>High-risk group for schizophrenia</kwd><kwd>follow-up of adolescent depression</kwd><kwd>attenuated positive symptoms</kwd><kwd>functional outcome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Омельченко М. А. Клинико-психопатологические особенности юношеских депрессий с аттенуированными симптомами шизофренического спектра / М. А. Омельченко // Психиатрия. – 2021. – 19 (1): 16-25.</mixed-citation><mixed-citation xml:lang="en">Omelchenko M. A. Clinical Features of Youth Depression with Attenuated Symptoms of the Schizophrenic Spectrum. Psihiatriya. 2021; 19 (1): 16-25. (In Russ.). doi: 10.30629/2618-6667-2021-19-1-16-25</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Andreasen N. C. Review the Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry Suppl. 1989; 7: 49–58. doi: 10.1192/S0007125000291496</mixed-citation><mixed-citation xml:lang="en">Andreasen N. C. Review the Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry Suppl. 1989; 7: 49–58. doi: 10.1192/S0007125000291496</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960; 23: 56–62. doi: 10.1136/jnnp.23.1.56</mixed-citation><mixed-citation xml:lang="en">Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960; 23: 56–62. doi: 10.1136/jnnp.23.1.56</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lemos-Giráldez S., Vallina-Fernández O., Fernández-Iglesias P., Vallejo-Seco G., Fonseca-Pedrero E., Paíno-Piñeiro M., Sierra-Baigrie S., García-Pelayo P., Pedrejón-Molino C., Alonso-Bada S., Gutiérrez-Pérez A., Ortega-Ferrández J. A. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res. 2009; 115 (2-3): 121-9. doi: 10.1016/j.schres.2009.09.011. Epub 2009 Sep 27. PMID: 19786339.</mixed-citation><mixed-citation xml:lang="en">Lemos-Giráldez S., Vallina-Fernández O., Fernández-Iglesias P., Vallejo-Seco G., Fonseca-Pedrero E., Paíno-Piñeiro M., Sierra-Baigrie S., García-Pelayo P., Pedrejón-Molino C., Alonso-Bada S., Gutiérrez-Pérez A., Ortega-Ferrández J. A. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res. 2009; 115 (2-3): 121-9. doi: 10.1016/j.schres.2009.09.011. Epub 2009 Sep 27. PMID: 19786339.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lewandowski K. E. Neuroprogression across the Early Course of Psychosis. J. Psychiatr. Brain Sci. 2020; 5: e200002. doi: 10.20900/jpbs.20200002</mixed-citation><mixed-citation xml:lang="en">Lewandowski K. E. Neuroprogression across the Early Course of Psychosis. J. Psychiatr. Brain Sci. 2020; 5: e200002. doi: 10.20900/jpbs.20200002</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lin A. Outcomes of nontransitioned cases in a sample at ultra‐high risk for psychosis. Am. J. Psychiatry. 2015; 172: 249–258. doi: 10.1176/appi.ajp.2014.13030418</mixed-citation><mixed-citation xml:lang="en">Lin A. Outcomes of nontransitioned cases in a sample at ultra‐high risk for psychosis. Am. J. Psychiatry. 2015; 172: 249–258. doi: 10.1176/appi.ajp.2014.13030418</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Malla A. Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial. World Psychiatry.2017; 16 (3): 278–286. doi: 10.1002/wps.20456</mixed-citation><mixed-citation xml:lang="en">Malla A. Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial. World Psychiatry.2017; 16 (3): 278–286. doi: 10.1002/wps.20456</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marín O. Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med. 2016; 22 (11): 1229–1238. doi: 10.1038/nm.4225</mixed-citation><mixed-citation xml:lang="en">Marín O. Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med. 2016; 22 (11): 1229–1238. doi: 10.1038/nm.4225</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">McGorry P. Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry. World Psychiatry. 2018; 17 (2): 133–142. doi: 10.1002/wps.20514</mixed-citation><mixed-citation xml:lang="en">McGorry P. Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry. World Psychiatry. 2018; 17 (2): 133–142. doi: 10.1002/wps.20514</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Miller T. J. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.Am. J. Psychiatry. 2002; 159: 863–865. doi: 10.1176/appi.ajp.159.5.863</mixed-citation><mixed-citation xml:lang="en">Miller T. J. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.Am. J. Psychiatry. 2002; 159: 863–865. doi: 10.1176/appi.ajp.159.5.863</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Miller T. J. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 1999 (70): 273–287. doi: 10.1023/A:1022034115078</mixed-citation><mixed-citation xml:lang="en">Miller T. J. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 1999 (70): 273–287. doi: 10.1023/A:1022034115078</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Polari A. Clinical trajectories in the ultra‐high risk for psychosis population. Schizophr. Res. 2018; 197: 550–556. doi: 10.1016/j.schres.2018.01.022</mixed-citation><mixed-citation xml:lang="en">Polari A. Clinical trajectories in the ultra‐high risk for psychosis population. Schizophr. Res. 2018; 197: 550–556. doi: 10.1016/j.schres.2018.01.022</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rutigliano G. Persistence or recurrence of non‐psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J Affect. Disord. 2016; 203: 101–110. doi: 10.1016/j.jad.2016.05.053</mixed-citation><mixed-citation xml:lang="en">Rutigliano G. Persistence or recurrence of non‐psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J Affect. Disord. 2016; 203: 101–110. doi: 10.1016/j.jad.2016.05.053</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schlosser D. A., Jacobson S., Chen Q., Sugar C. A., Niendam T. A., Li G., Bearden C. E., Cannon T. D. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012; 38 (6): 1225-33. doi: 10.1093/schbul/sbr098.</mixed-citation><mixed-citation xml:lang="en">Schlosser D. A., Jacobson S., Chen Q., Sugar C. A., Niendam T. A., Li G., Bearden C. E., Cannon T. D. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012; 38 (6): 1225-33. doi: 10.1093/schbul/sbr098.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
